Volume 41,Issue 2,2022 Table of ContentsDownload Contents

   
Other Issues:  
  

Experimental Research

Discussion on the mechanisms of couplet medicine of “Bupleuri Radix-Angelicae Sinensis Radix” for mammary gland hyperplasia based on network pharmacology and molecular docking
  YUAN Mingyang1, ZHOU Xuegang2, HU Dandan2, JIANG Lei2, YANG Bo1, PENG Haisheng2
  Published February 25, 2022
  2022,41(2):71-78 [Abstract(2675)]  [View PDF 4.63 M (2901)]
  
Separation and purification of casein anticoagulant peptide and determination of its anticoagulant activity
  LIU Lisha1, MIAO Yanli1, CHEN Shaohong2, ZHANG Liu1, LU Xiao1
  Published February 25, 2022
  2022,41(2):79-82 [Abstract(2544)]  [View PDF 1.80 M (2757)]
  
Study on Acute and Long-Term Toxicity of Ganlanqianggu Tablets
  ZHOU Zuxuan1,2, ZHANG Ting1,2, LIANG Guodong1,2, LIU Weidong1,2, XIAO Yunfeng3
  Published February 25, 2022
  2022,41(2):83-87,121 [Abstract(2654)]  [View PDF 1.70 M (2473)]
  
Simultaneous determination of five components in Ganmaoshufeng Tablets by HPLC
  LI Qi, TIAN Jing
  Published February 25, 2022
  2022,41(2):88-91 [Abstract(2512)]  [View PDF 1.27 M (2258)]
  
Study on quality control of the skin ingredients of donkey in donkey-hide gelatin pastry
  ZHAO Yanxia1,2, JIANG Shuyin2, GONG Liping2, SHI Feng2, CHENG Chunlei2, LUO Xuegang1
  Published February 25, 2022
  2022,41(2):92-95,106 [Abstract(2463)]  [View PDF 1.59 M (2480)]
  

Traditional Chinese Medicine Processing Column

Research on the historical evolution of Alisma orientale
  ZHANG Liqiang1, LI Yuanyuan1, JU Chengguo1,2
  Published February 25, 2022
  2022,41(2):96-99 [Abstract(2545)]  [View PDF 1.14 M (2197)]
  
Optimization of Processing Technology of Psoraleae Fructus with Wine
  CHEN Lidong, ZHANG Xueshun, LIU Xiaoqian
  Published February 25, 2022
  2022,41(2):100-103 [Abstract(2462)]  [View PDF 1.15 M (2133)]
  

Review

Research and recent progress of rectal drug delivery system
  ZHOU Chunhui1,2, HAN Xiaolu2, LI Meng2, WANG Zengming2, LI Chunmei1, WANG Xiangtao1, ZHENG Aiping2
  Published February 25, 2022
  2022,41(2):107-112 [Abstract(2356)]  [View PDF 2.33 M (2685)]
  
Research progress of signal pathways related to the pathogenesis of uric acid nephropathy
  GAO Tianshu1, XIAO Yuxiao1, SU Xiaoyu1, LI Jiaqi1, CHEN Jiajia2, HU Weifeng3, JIA Yuhan1, WANG Xing1,4, CHEN Zhen1
  Published February 25, 2022
  2022,41(2):113-116 [Abstract(2475)]  [View PDF 1.15 M (2482)]
  
Research progress on cardiovascular activities of berberine hydrochloride
  LIN Qingwei1, LI Peibo1, WU Hao1, PENG Wei1, ZHONG Hualin1, SU Weiwei1, CHENG Chunlei2, WANG Yonggang1
  Published February 25, 2022
  2022,41(2):117-121 [Abstract(2272)]  [View PDF 1.19 M (2187)]
  
The overview of techniques of AD drug developments targeting tau protein
  ZHONG Suyue, TAN Qiulong, YAO Xuanbao, YANG Jiaying, XIAO Shifeng
  Published February 25, 2022
  2022,41(2):122-126 [Abstract(2399)]  [View PDF 953.46 K (2093)]
  

Clinical Pharmacy

Clinical observation on the effect of Simiao Powder on coagulation index in the treatment of acute gouty arthritis
  JING Rongyue, XU Lei, XU Chengsong, XU Meimei, GUO Liang, CHEN Yueyue
  Published February 25, 2022
  2022,41(2):127-130 [Abstract(2606)]  [View PDF 1.16 M (2042)]
  
Application of subject-achieving quality control circle in improving pharmaceutical care for patients with chronic hepatitis B
  GONG Yinhua, ZHANG Ping, HONG Xiao, CHEN Rong, XU Wenjie, ZHU Jianguo
  Published February 25, 2022
  2022,41(2):131-135,140 [Abstract(2437)]  [View PDF 2.12 M (2510)]
  

Adverse Drug Reactions

Retrospective analysis of 1120 adverse drug reactions/events
  LIN Mao1, LIU Minhui1, CHEN Chongze1, DAI Hengfen2
  Published February 25, 2022
  2022,41(2):136-140 [Abstract(2521)]  [View PDF 1.16 M (2281)]
  

News in Brief

《药学研究》杂志2022年度征订启事
  Published February 25, 2022
  2022,41(2):103 [Abstract(2553)]  [View PDF 1.00 M (2178)]
  
《药学研究》关于抵制学术不端行为的声明
  Published February 25, 2022
  2022,41(2):130 [Abstract(2093)]  [View PDF 1023.30 K (2335)]
  

Contents

Protection of subjects in phase I clinical trials during normalized anti-epidemic period
  CAI Baole, MA Pengcheng
  Published February 25, 2022
  2022,41(2):104-106 [Abstract(2408)]  [View PDF 1.11 M (2309)]